'Special
Considerations for the Diagnosis and Treatment of Invasive Pulmonary
Aspergillosis.
McCarthy MW, Walsh TJ.
Expert Rev Respir Med. 2017 Jun 8.
Abstract
Allergic Bronchopulmonary Aspergillosis in Cystic Fibrosis: MR Imaging
of Airway Mucus Contrasts as a Tool for Diagnosis.
Dournes G, Berger P, Refait J, et al
adiology. 2017 May 22:162350.
Abstract
An
analytical
and clinical evaluation of the PathoNostics AsperGenius® Assay for the
detection of invasive aspergillosis and resistance to azole antifungal
drugs direct from plasma samples.
White PL, Posso RB, Barnes RA.
J
Clin Microbiol. 2017 May 17
Abstract
Prognostic value of galactomannan: current evidence for
monitoring response to antifungal therapy in patients with invasive
aspergillosis
Kovanda LL, Desai AV, Hope WW.
J Pharmacokinet Pharmacodyn. 2017 Feb 8.
Abstract
Development and evaluation of enzyme-linked immunosorbent
assay of nucleic acid sequence-based amplification for diagnosis of
invasive aspergillosis.
Du L, Xia Y, He Y, et al
AMB Express. 2016 Dec;6(1):91.
Abstract
Galactomannan enzyme immunoassay and quantitative Real
Time PCR as tools to evaluate the exposure and response in a rat model
of aspergillosis after posaconazole prophylaxis.
Cendejas-Bueno E, Forastiero A,
et al
Enferm Infecc Microbiol Clin.
2016 Nov;34(9):571-576
Abstract
Performance evaluation of multiplex PCR including
Aspergillus-not so simple!
Alanio A, Bretagne S.
Med Mycol. 2016 Sep 23.
Abstract
Diagnosis of invasive fungal infections in hematological
patients by combined use of galactomannan, 1,3-beta-D-glucan,
Aspergillus PCR, multifungal DNA-microarray and Aspergillus azole
resistance PCRs in blood and bronchoalveolar lavage samples - results of
a prospective multicenter study.
Boch T, Spiess B, Cornely OA, et al
Clin Microbiol Infect. 2016 Jul 5.
Abstract
Analysis of peritoneal galactomannan for the diagnosis of Aspergillus
peritonitis.
Dichtl K, Wagener J, Tschöp J, Ney L.
Infection. 2016 May 9.
Abstract
Aspergillus fumigatus detection in blood from critical
ill ICU patients using the SeptiFast assay
Steinmann J, Buer J, Rath PM.
J Clin Microbiol. 2016 May 4.
Abstract
Comparison of Serum Galactomannan and 1,3-Beta-D-Glucan Determination
for Early Detection of Invasive Pulmonary Aspergillosis in Critically
Ill Patients with Hematological Malignancies and Septic Shock.
Lahmer T, Rasch S, Schnappauf C,
et al
Mycopathologia.
2016 May 3.
Abstract
Galactomannan in Bronchoalveolar Lavage Fluid for
Diagnosis of Invasive Aspergillosis in Non-Hematological
Patients.
Fortún J, Martín-Dávila P, Gomez Garcia de la Pedrosa E, et al
J Infect. 2016
Mar 26. pii: S0163-4453(16)30007-X.
Abstract
FULL-TEXT ARTICLE
Evaluation of a serology quantitative assay for diagnosing chronic
pulmonary aspergillosis.
Fujiuchi S, Fujita Y, Suzuki H, et al
J Clin Microbiol.
2016 Mar 23.
Paper
FULL-TEXT ARTICLE
Detection
of a Serum Siderophore by LC-MS/MS as a Potential Biomarker of Invasive
Aspergillosis.
Carroll CS, Amankwa LN, Pinto LJ, et
al
PLoS One. 2016 Mar
14;11(3):e0151260.
Paper
Invasive Aspergillosis: Current Strategies for Diagnosis
and Management.
Cadena J, Thompson GR 3rd, Patterson TF.
Infect Dis Clin North Am. 2016 Mar;30(1):125-42.
Abstract
The role of basophil activation test in allergic
bronchopulmonary aspergillosis and Aspergillus fumigatus sensitization
in cystic fibrosis patients.
Katelari A, Tzanoudaki M, Noni M,
et al
J Cyst Fibros.
2016 Feb 25.
Abstract
Prospective evaluation of a new Aspergillus IgG EIA kit
for the diagnosis of chronic and allergic pulmonary aspergillosis.
Dumollard C, Bailly S, Perriot S,
et al
J Clin Microbiol.
2016 Feb 17.
Abstract
Diagnostics and susceptibility testing in Aspergillus.
Bernal-Martínez L, Alastruey-Izquierdo A, Cuenca-Estrella M.
Future Microbiol.
2016 Feb 5.
Abstract
Clinical validity of bis(methylthio)gliotoxin for the
diagnosis of invasive aspergillosis.
Vidal-García M, Domingo MP, De Rueda B, et al
Appl Microbiol Biotechnol. 2015 Dec 17.
Abstract
Comparison of six Aspergillus-specific IgG assays for the
diagnosis of chronic pulmonary aspergillosis (CPA).
Page ID, Richardson MD, Denning DW.
J Infect. 2015 Dec 8.
Abstract
Diagnostic performance of galactomannan antigen testing
in cerebrospinal fluid.
Chong GM, Maertens JA, Lagrou K,
et al
J Clin Microbiol. 2015 Dec 9.
Abstract
FULL-TEXT ARTICLE
Improved Detection of Invasive Pulmonary Aspergillosis Arising during
Leukemia Treatment Using a Panel of Host Response Proteins and Fungal
Antigens.
Brasier AR, Zhao Y, Spratt HM, Wiktorowicz JE, et a
PLoS
One. 2015 Nov
18;10(11):e0143165.
Paper
Polymerase chain reaction blood tests for the diagnosis
of invasive aspergillosis in immunocompromised people.
Cruciani M, Mengoli C, Loeffler J, et al
Cochrane Database Syst Rev. 2015 Oct 1;10:CD009551.
Abstract
FULL-TEXT ARTICLE
RNAseq analysis
of Aspergillus fumigatus in blood reveals a just wait and see resting
stage behavior.
Irmer H, Tarazona S, Sasse C, et al
BMC Genomics. 2015 Aug 27;16:640.
Paper
FULL-TEXT ARTICLE
Evaluation of
the Double Agar Gel Immunodiffusion Test and of the Enzyme-Linked
Immunosorbent Assay in the Diagnosis and Follow-Up of Patients with Chronic
Pulmonary Aspergillosis.
Azevedo PZ, Sylvestre TF, Cavalcante Rde S, et al
PLoS One.
2015 Aug 13;10(8):e0134841
Paper
Performance Characteristics of Galactomannan and β-d-Glucan
in High-Risk Liver Transplant Recipients.
Singh N, Winston DJ, Limaye AP,
et al
Transplantation. 2015 Jun 4
Abstract
FULL-TEXT
ARTICLE
Genomic
Context of Azole Resistance Mutations in Aspergillus fumigatus Determined
Using Whole-Genome Sequencing.
Abdolrasouli A, Rhodes J, Beale MA, et al
MBio. 2015 Jun 2;6(3).
Paper
Performance of lateral flow device and galactomannan for the
detection of Aspergillus species in bronchoalveolar fluid of patients at
risk for invasive pulmonary aspergillosis.
Miceli MH, Goggins MI, Chander P, et al
Mycoses.
2015 Jun;58(6):368-74.
Abstract
Diagnostic Accuracy of a Novel Lateral-Flow Device in
Invasive Aspergillosis: a Meta-Analysis.
Pan Z, Fu M, Zhang J,
et al
J Med Microbiol. 2015 May 22.
Abstract
FULL-TEXT
ARTICLE
Paving the way for predictive diagnostics and personalized treatment of
invasive aspergillosis.
Oliveira-Coelho A, Rodrigues F,
et al
Front Microbiol. 2015
May 5;6:411.
Paper
FULL-TEXT
ARTICLE
Genetic Analysis Using an Isogenic Mating Pair of Aspergillus fumigatus
Identifies Azole Resistance Genes and Lack of MAT Locus's Role in Virulence.
Losada L, Sugui JA, Eckhaus MA, et al
PLoS Pathog. 2015 Apr 24;11(4):e1004834.
Paper
An analytical and clinical evaluation of the PathoNostics
AsperGenius® Assay for detection of Invasive Aspergillosis and resistance to
azole antifungal drugs when testing serum samples.
White PL, Posso RB, Barnes RA. et al
J Clin Microbiol. 2015 Apr 22
Abstract
Aspergillus Lateral-Flow Device and qPCR testing in Broncho-Alveolar
Lavage Fluid: A Combination Biomarker Approach for the Clinical Diagnosis of
Invasive Pulmonary Aspergillosis.
Johnson GL, Sarker SJ, Nannini F,
et al
J Clin Microbiol. 2015 Apr 22
Abstract
Multicenter evaluation of a lateral-flow device test for
diagnosing invasive pulmonary aspergillosis in ICU patients.
Eigl S, Prattes J, Lackner M, et al
Crit Care.
2015 Apr 17;19
Abstract
Comparison of computed tomographic findings in pulmonary
mucormycosis and invasive pulmonary aspergillosis.
Jung J, Kim MY, Lee HJ,
et al
Clin Microbiol Infect.
2015 Apr 13
Abstract
FULL-TEXT ARTICLE
Importance of Operational Factors in the Reproducibility of Aspergillus
Galactomannan Enzyme Immune Assay.
Guigue N, Lardeux S, Alanio A, et al
PLoS One. 2015 Apr 10;10(4):e0124044
Paper
Diagnosis of Invasive Aspergillosis: Recent Developments and
Ongoing Challenges.
Arvanitis M, Mylonakis E.
Eur J Clin Invest.
2015 Apr 7.
Abstract
A Breath Fungal Secondary Metabolite Signature to Diagnose
Invasive Aspergillosis.
Koo S, Thomas HR, Daniels SD, et al
Clin Infect Dis. 2014 Oct 22
Abstract
Host Biomarkers of Invasive Pulmonary Aspergillosis To
Monitor Therapeutic Response.
Krel M, Petraitis V, Petraitiene R, et al
Antimicrob Agents Chemother.
2014 Jun;58(6):3373-3378
Abstract
Use and limits of (1-3)-β-D-Glucan Assay (Fungitell(R)),
compared to galactomannan determination (Platelia™ Aspergillus) for
diagnosis of invasive aspergillosis.
Sulahian A, Porcher R, Bergeron A, et al
J Clin Microbiol. 2014 Apr 16
Abstract
Independent contribution of bronchoalveolar lavage and serum
galactomannan in the diagnosis of invasive pulmonary aspergillosis.
Fisher CE, Stevens AM, Leisenring W, et al
Transpl Infect Dis.
2014 Apr 12.
Abstract
FULL-TEXT ARTICLE
Development
and Validation of an HPLC-MS/MS Method for the Early Diagnosis of
Aspergillosis.
Cerqueira LB, de Francisco TM, Gasparetto JC,
et al
PLoS One.
2014 Apr 1;9(4):e92851.
Paper
PCR as a Screening Test for Invasive Aspergillosis in
Haematological Patients: A Pilot Study.
da Silva TV, Carneiro LC, Dos Santos Ramos F, et al
Mycopathologia. 2013 Dec 6
Abstract
Aspergillus PCR based investigation of fresh tissue and
effusion samples in patients with suspected invasive aspergillosis enhances
diagnostic capabilities.
Reinwald M, Spiess B, Heinz WJ, et al
J Clin Microbiol. 2013 Oct 9
Abstract
Use of Mycological, nested PCR, and Real-time PCR Methods on
BAL Fluids for Detection of Aspergillus fumigatus and A. flavus in Solid
Organ Transplant Recipients.
Zarrinfar H, Mirhendi H, Makimura K, et al
Mycopathologia. 2013 Sep 18.
Abstract
FULL-TEXT ARTICLE
Evaluation of MycAssay™ Aspergillus for Diagnosis of Invasive Pulmonary
Aspergillosis in Patients without Hematological Cancer.
Guinea J, Padilla C, Escribano P, et al
PLoS One. 2013 Apr 19;8(4):e61545.
Paper |